Skip to content

Effects of Local Protocols on Duration of Chest Tube Therapy Following Thoracic Surgery

Prospective, Non Randomized Investigator Initiated Multi-centre Trial on the Effects of Local Treatment Protocols on the Duration of Chest Tube Therapy Following Thoracic Surgery in Germany

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01467622
Enrollment
80
Registered
2011-11-09
Start date
2009-04-30
Completion date
2011-10-31
Last updated
2013-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Air Leak

Keywords

chest tube drainage, pulmonary air leak, lung resection

Brief summary

The effect of local chest-tube management protocols on the duration of chest-tube therapy following thoracic surgery was analyzed in four German specialized Thoracic Surgery Units. The primary study objective was the duration of chest tube therapy in postoperative patients.

Detailed description

The management of chest tubes is probably one of the most critical aspects in patient care in thoracic surgery and defines the required length of postoperative hospital stay in the majority of patients. So far, no generally accepted recommendations exist for postoperative chest tube management to streamline the postoperative stay. Instead, decision making in most thoracic surgery units is based on team preferences and individual training rather than scientific data. Therefore, digital pleural drainage systems represent a useful tool to standardize existing intradepartmental protocols for chest tube management. However, for the development of generally accepted protocol-recommendations, the diverging interdepartmental treatment protocols have to be analyzed and compared for superiority. In this IIT, the effect of different chest tube management protocols on chest tube duration is analyzed in four German Thoracic Surgery units.

Interventions

PROCEDUREChest tube removal

Chest tube removal on the basis of local recommendations for postoperative chest tube management

Sponsors

Medela AG
CollaboratorINDUSTRY
Schillerhoehe Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* age 18-85 * following pulmonary wedge resection, anatomic segmentectomy, or lobectomy

Exclusion criteria

* surgery for spontaneous pneumothorax (primary and secondary) * surgery for pleural empyema * present medication with corticoids, immunosuppressive drugs or platelet aggregation inhibitors other than Aspirin * history of chemotherapy, radiotherapy of the chest, or previous ipsilateral thoracic surgery

Design outcomes

Primary

MeasureTime frameDescription
chest tube therapy durationparticipants are followed for the duration of hospital stay, an expected average of 5 daysnumber of days following thoracic surgery until chest tube was removed

Secondary

MeasureTime frameDescription
presence of pulmonary air leakparticipants are followed for the duration of hospital stay, an expected average of 4 daysnumber of days the Medela Thopaz device detected a pulmonary air leak following thoracic surgery

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026